Key terms

About FOLD

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest FOLD news

Today 5:05am ET Buy Rating Affirmed on Strong Growth and Positive Drug Developments by TipRanks Yesterday 1:25pm ET Amicus (FOLD) Gets a Hold from Needham by TipRanks Yesterday 7:20am ET Amicus sees FY24 revenue growth of 25%-30% by TipRanks Yesterday 7:19am ET Amicus reports Q1 EPS (16c), consensus (7c) by TipRanks Mar 18 7:13am ET Amicus price target lowered to $19 from $21 at JPMorgan by TipRanks Mar 06 6:19am ET Amicus’s Growth Trajectory Reinforces Buy Rating Amid Strong Product Prospects and Revenue Milestones by TipRanks Mar 01 5:21am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amicus (FOLD), Xenon (XENE) and Veeva Systems (VEEV) by TipRanks Mar 01 1:04am ET Buy Rating Affirmed: Amicus’s Strong Product Launch and Growth Trajectory by TipRanks Feb 29 5:40am ET Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD) by TipRanks Feb 29 5:29am ET Needham Sticks to Its Hold Rating for Amicus (FOLD) by TipRanks Feb 28 3:15pm ET Buy Rating Affirmed for Amicus with Strong Growth and Promising Outlook by TipRanks Feb 28 7:07am ET Amicus reports Q4 EPS 1c, consensus (6c) by TipRanks

No recent press releases are available for FOLD

FOLD Financials

1-year income & revenue

Key terms

FOLD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

FOLD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - MAY 03: Traders work on the floor of the New York Stock Exchange (NYSE) on May 03, 2024 in New York City. The Dow surged over 400 points in morning trading as new economic numbers showed that the central bank may cut interest rates sooner than expected. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images North America/Getty Images
There’s a surprising bit of good news lurking in the stock market
Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse